KXV01 TCR Lentinvivo
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KXV01 TCR Lentinvivo, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors [Phase 1]